Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + propofol vs opioid + propofol for bronchoscopy sedation in adults with predicted difficult airway
ChiCTR2600123778Phase 4Not yet recruiting
- Sponsor
- Ganzhou People's Hospital
- Start
- Apr 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anoxemia and difficult airway comparing S group (sufentanil + propofol) with E group (esketamine + propofol) (2 arms). Primary endpoint: Hypoxemia during bronchoscopy. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
esketaminesufentanilpropofol
03
Conditions
anoxemiadifficult airway
Beyond the preview
Go deeper on ChiCTR2600123778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123778.